A case report of neuromyelitis optica spectrum disorder induced by pembrolizumab treatment for lung adenocarcinoma: a clinical and immunohistochemical study

Peer Review reports

Original Submission
22 Jun 2022	Submitted	Original manuscript
22 Aug 2022	Reviewed	Reviewer Report
23 Aug 2022	Reviewed	Reviewer Report
2 Sep 2022	Author responded	Author comments - Shigeki Hirano
Resubmission - Version 2
2 Sep 2022	Submitted	Manuscript version 2
16 Nov 2022	Reviewed	Reviewer Report
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
24 Nov 2022	Editorially accepted
15 Dec 2022	Article published	10.1186/s12883-022-02987-6

Back to article page